))
Bridging the Dopamine Gap with Nourianz | PD Medications, Purposes, and Mechanisms 2.0
Manage episode 407360699 series 3559715
Inhalt bereitgestellt von Dr. Michael Hyland, DPT, CEEAA, CFPS, Dr. Michael Hyland, DPT, CEEAA, and CFPS. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Dr. Michael Hyland, DPT, CEEAA, CFPS, Dr. Michael Hyland, DPT, CEEAA, and CFPS oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
OK, it's time for part THREE of our PD Medications, Purposes, and Mechanisms #miniseries! In part three you will learn about Adenosine A2A Antagonists and how they can help in management of the symptoms of PD. Keep scrolling down to access the link to the Parkinson's Foundation page about Adenosine A2A Antagonists. The video version of this episode is here.
Join this channel to get access to member's only content and perks:
https://www.youtube.com/channel/UC0g3abv8hkaqZbGD8y1dfYQ/join
https://www.patreon.com/pdeducation
Adenosine A2A Antagonist Information: https://www.parkinson.org/living-with-parkinsons/treatment/prescription-medications/adenosine-a2a-ntagonists
Medical Disclaimer All information, content, and material of this video is for informational purposes only and not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.
Affiliate disclaimer: Keep in mind that links used for recommended products may earn me a commission when you make purchases. However, this does not impact what products I recommend. If I recommend a specific product it is because it has been vetted by myself or based on personal use
#parkinson #parkinsonsawareness #parkinsonsdisease #parkinsons #medication #parkinsons #podcast #lecture
92 Episoden
Teilen
